EyePoint Pharmaceuticals
EYPT
#10613
Rank
NZ$48.71 M
Marketcap
NZ$0.43
Share price
-11.36%
Change (1 day)
-98.24%
Change (1 year)

EPS for EyePoint Pharmaceuticals (EYPT)

EPS in 2026 (TTM): NZ-$6.51

According to EyePoint Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$6.84. In 2025 the company made an earnings per share (EPS) of NZ-$5.78 a decrease over its 2024 EPS that were of NZ-$4.22.

EPS history for EyePoint Pharmaceuticals from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$6.5112.62%
2025NZ-$5.7836.8%
2024NZ-$4.22
2022NZ-$4.9935.15%
2021NZ-$3.69-42.45%
2020NZ-$6.42-37.32%
2019NZ-$10.24-57.89%
2018NZ-$24.31125.42%
2017NZ-$10.796.89%
2016NZ-$10.09-20.01%
2015NZ-$12.61
2013NZ-$10.2421.74%
2012NZ-$8.41-58.18%
2011NZ-$20.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Nymox Pharmaceutical
NYMX
NZ-$0.11-98.40% Bahamas
NRC Health
NRC
NZ$0.53-107.75%๐Ÿ‡บ๐Ÿ‡ธ USA